Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT00552149
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Advanced Biliary Cancer
Interventions
DRUG:
Gemox, Cetuximab
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators
[object Object]